SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001878961-22-000001
Filing Date
2022-07-07
Accepted
2022-07-07 16:36:29
Documents
1
Period of Report
2022-06-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3526
  Complete submission text file 0001878961-22-000001.txt   4972
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Issuer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3274 ROSS ROAD PALO ALTO CA 94303
Business Address
Anderson Glen R. (Reporting) CIK: 0001878961 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40652 | Film No.: 221072034